Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 11, 2013, Pages 4180-4183

  Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Immunosupression; Viral persistence

Indexed keywords

ARTICLE; AUTOIMMUNITY; CELL EXPANSION; CYTOKINE STORM; ENDOTHELIUM CELL; HOST; IMMUNE COMPLEX DISEASE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION RESISTANCE; INFLUENZA; INFLUENZA VIRUS; LYMPHOCYTE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; AUTOIMMUNITY; IMMUNE TOLERANCE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84875015344     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1222025110     Document Type: Article

References (54)

1. Jenner E (1798) An Inquiry Into the Causes and Effects of Variolae, a Disease Discovered in Some of the Western Counties of England, Particularly Gloucestershire and Known by the Name of Cowpox (Sampson Low, London).
2. Loeffler F, Frosch P (1898) Berichte der Kommission zur Erforschung der Maul und Klauenseuche bei dem Institut fur Infektionskrankheiten in Berlin. Zentbl Bakt Parasit Kde Abt 1(23):371-391.
3. Beijerinck MW (1899) Bemerkung zu dem Aufsatz von Herrn Iwanowsky uber die Mosaikkrankheit der Tabakspflanze. Zentbl. Bakt Parasit Kde Abt 1(5):310-311.
4. Ivanovski DI (1899) Ueber die Mosaikkrankheit der Tabakspflanze. Zentbl Bakt Parasit Kde Abt 2(5):250-254.
5. Oldstone MBA (2010) Viruses, Plagues, and History (Oxford Univ Press, Oxford, UK), pp 10-40.
6. Levine AJ, Enquest LW (2007) History of virology. Fields Virology, eds Knipe DM, Howley PM (Lippincott Williams and Wilkins, Philadelphia), 5th Ed, pp 3-24.
7. zur Hausen H (2009) The search for infectious causes of human cancers: Where and why (Nobel lecture). Angew Chem Int Ed Engl 48(32):5798-5808.
8. Oldstone MBA (1975) Virus Neutralization and Virus-Induced Immune Complex Disease: Virus-Antibody Union Resulting in Immunoprotection or Immunologic Injury- Two Sides of the Same Coin (S. Karger, Basel), pp 84-119.
9. Zajac AJ, et al. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188(12):2205-2213.
10. Wherry EJ (2011) T cell exhaustion. Nat Immunol 12(6):492-499.
11. Barber DL, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439(7077):682-687.
12. Brooks DG, et al. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12(11):1301-1309.
13. Brooks DG, et al. (2008) IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc Natl Acad Sci USA 105(51): 20428-20433.
14. Oldstone MBA (2002) Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol 263:83-117.
15. Oldstone MBA, Campbell KP (2011) Decoding arenavirus pathogenesis: Essential roles for alpha-dystroglycan-virus interactions and the immune response. Virology 411(2): 170-179.
16. Fugier-Vivier I, et al. (1997) Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 186(6): 813-823.
17. Hahm B, Cho JH, Oldstone MB (2007) Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: Selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis. Virology 358(2):251-257.
18. Ng CT, Sullivan BM, Oldstone MB (2011) The role of dendritic cells in viral persistence. Curr Opin Virol 1(3):160-166.
19. Sevilla N, et al. (2000) Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med 192(9):1249-1260.
20. Sevilla N, McGavern DB, Teng C, Kunz S, Oldstone MBA (2004) Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J Clin Invest 113(5):737-745.
21. Popkin DL, et al. (2011) Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner. Cell Host Microbe 9(3): 212-222.
22. Ng CT, Oldstone MB (2012) Infected CD8α-dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection. Proc Natl Acad Sci USA 109(35):14116-14121.
23. Mueller SN, et al. (2007) Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection. Proc Natl Acad Sci USA 104(39):15430-15435.
24. Ng CT, Nayak BP, Schmedt C, Oldstone MB (2012) Immortalized clones of fibroblastic reticular cells activate virus-specific T cells during virus infection. Proc Natl Acad Sci USA 109(20):7823-7828.
25. Burnet FM, Fenner F (1949) The Production of Antibodies (MacMillan, New York).
26. Oldstone MB (1994) The role of cytotoxic T lymphocytes in infectious disease: History, criteria, and state of the art. Curr Top Microbiol Immunol 189:1-8.
27. Oldstone MBA, Dixon FJ (1967) Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science 158(3805):1193-1195.
28. Oldstone MBA, Aoki T, Dixon FJ (1972) The antibody response of mice to murine leukemia virus in spontaneous infection: Absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci USA 69(1):134-138.
29. Oldstone MB, Del Villano BC, Dixon FJ (1976) Autologous immune responses to the major oncornavirus polypeptides in unmanipulated AKR/J mice. J Virol 18(1):176-181.
30. Jamieson BD, Ahmed R (1988) T-cell tolerance: Exposure to virus in utero does not cause a permanent deletion of specific T cells. Proc Natl Acad Sci USA 85(7):2265-2268.
31. Jamieson BD, Somasundaram T, Ahmed R (1991) Abrogation of tolerance to a chronic viral infection. J Immunol 147(10):3521-3529.
32. Kim PS, Ahmed R (2010) Features of responding T cells in cancer and chronic infection. Curr Opin Immunol 22(2):223-230.
33. Blackburn SD, Wherry EJ (2007) IL-10, T cell exhaustion and viral persistence. Trends Microbiol 15(4):143-146.
34. de la Torre JC, Oldstone MBA (1996) Anatomy of viral persistence: Mechanisms of persistence and associated disease. Adv Virus Res 46:311-343.
35. Oldstone MBA (1993) Rous-Whipple Award Lecture. Viruses and diseases of the twenty-first century. Am J Pathol 143(5):1241-1249.
36. Oldstone MB (1998) Molecular mimicry and immune-mediated diseases. FASEB J 12(13): 1255-1265.
37. Emonet SF, Garidou L, McGavern DB, de la Torre JC (2009) Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci USA 106(9):3473-3478.
38. Sullivan BM, et al. (2011) Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and longterm persistence. Proc Natl Acad Sci USA 108(7):2969-2974.
39. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG (1997) Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 275(5307):1793-1796.
40. Johnson NP, Mueller J (2002) Updating the accounts: Global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 76(1):105-115.
41. Tumpey TM, et al. (2005) Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310(5745):77-80.
42. Pappas C, et al. (2008) Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci USA 105(8):3064-3069.
43. Kobasa D, et al. (2004) Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431(7009):703-707.
44. Fukuyama S, Kawaoka Y (2011) The pathogenesis of influenza virus infections: The contributions of virus and host factors. Curr Opin Immunol 23(4):481-486.
45. Oldstone MB, Teijaro JR, Walsh KB, Rosen H (2013) Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection. Virology 435(1):92-101.
46. Arankalle VA, et al. (2010) Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS ONE 5(10):e13099.
47. Kash JC, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443(7111):578-581.
48. Tisoncik JR, et al. (2012) Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76(1): 16-32.
49. Marsolais D, et al. (2009) A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci USA 106(5):1560-1565.
50. Walsh KB, et al. (2011) Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci USA 108 (29):12018-12023.
51. Teijaro JR, et al. (2011) Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146(6):980-991.
52. Marsolais D, et al. (2008) Local not systemic modulation of dendritic cell S1P receptors in lung blunts virus-specific immune responses to influenza. Mol Pharmacol 74(3): 896-903.
53. Rosen H, Gonzalez-Cabrera PJ, Sanna MG, Brown S (2009) Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem 78:743-768.
54. Rosen H, Sanna MG, Cahalan SM, Gonzalez-Cabrera PJ (2007) Tipping the gatekeeper: S1P regulation of endothelial barrier function. Trends Immunol 28(3):102-107.